Dataset Viewer
Auto-converted to Parquet Duplicate
prompt
stringlengths
931
2.5k
completion
stringclasses
2 values
split
stringclasses
1 value
query_record_id
stringlengths
64
64
retrieval_record_id
stringlengths
64
64
query_smiles
stringlengths
1
1.05k
retrieval_smiles
stringlengths
1
1.05k
canonical_endpoint_key
stringclasses
160 values
assay_concept
stringclasses
5 values
pair_id
stringlengths
64
64
query_source_record_id
stringlengths
1
7
retrieval_source_record_id
stringlengths
1
7
query_input_sha256
stringlengths
64
64
retrieval_input_sha256
stringlengths
64
64
target_distribution
dict
metadata
dict
distance
float64
0
1.14k
target_z
float64
-118.87
6.21
target_a
float64
0.1
0.9
target_b
float64
0.1
0.9
binary_label
int64
is_decisive
bool
2 classes
ranking_query_id
stringclasses
0 values
ranking_member_index
int64
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C(O)c1ccccc1O</SMILES> - measured process: f...
(B)
train
4b6827e58ae97c2116e64efb5cf3c73f9cf55c8e81a7d6b106b22648c714f8c9
91d8c05f43aa4eb90d5f1c390603137b9923937dca5e34b5c60feb01aad013c6
COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1
O=C(O)c1ccccc1O
bioavailability_ma/fraction_absorbed/explicit_rate_constant/v2
Fa
ef436bec5420b4c696716c8327f2300c4059789f53db7cded8315029102df8f9
ext_4
ext_2
73eae84e9f26937890e2dc1533a46302d26459f8945280baa4ffc5af271c5c2a
bbf319dca8f3015f31e76b8f4bdafe4eb9727f995d4a92b5382b1d836b672437
{ "transfer": 0.4497371111478503, "nontransfer": 0.5502628888521497 }
{ "soft_targets": { "(A)": 0.4497371111478503, "(B)": 0.5502628888521497 }, "groups": { "assay_concept": "Fa" }, "target_z": -0.252649848384573 }
52.287875
-0.25265
0.449737
0.550263
null
false
null
null
You are comparing two molecules for a gut-wall availability / intestinal efflux transport (Fg) assay. Values reported under different assay systems (e.g. Caco-2 vs. MDCK, or different transporter overexpression lines) are not directly comparable, so both records below share the same assay system by construction. Two m...
(B)
train
fbdbeaed96d8a1b2df7929176a163d6ca6eaf3b09717964e06fe5f39292c5f4b
0a54d58e020ab2192c5e85ea2ec88e8d417bbba5a0a9b670e04cd28f3a3fdce1
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
bioavailability_ma/bidirectional_permeability/papp_unspecified/v2
Fg
5b1eeb65eec8b8f2e51ab9d31d460c3f94e81e9fdf3413360cafed7877db7d25
ext_54
ext_53
4de3c3e46ed0cbe79615350662c4ea472edd477ca6662a82b6b8c0db527b08bc
f99457508c22d8dcc0447b6303c2b28b5d6fdb0904e8f66448a8392865f97ade
{ "transfer": 0.10000000214209513, "nontransfer": 0.8999999978579049 }
{ "soft_targets": { "(A)": 0.10000000214209513, "(B)": 0.8999999978579049 }, "groups": { "assay_concept": "Fg" }, "target_z": -19.738337900741485 }
237.285088
-19.738338
0.1
0.9
null
true
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(B)
train
88a5e0f9aa0786951a88be4559a67338717fa1784b6b204a16039560f83d653b
943f613c5716fdf0807a7ea3f8ac30cda67d7a28afa70784bb3b3c77faa39599
O=C1CC=Cc2nc3ccccc3nc21
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
e42a7fdadac37f029304af602bca9b9529d6da869d3b3eaa666f4b273e8182b7
ext_31
ext_33
018fea87d7b6bd8e03fa0048a1f6207979d3f73092a9a220c934293cd9dffee2
7ef4aa01ab6153a8662b748601608a6aeaefb4205655feefdf4e542a3ebc8de1
{ "transfer": 0.10009789410218328, "nontransfer": 0.8999021058978167 }
{ "soft_targets": { "(A)": 0.10009789410218328, "(B)": 0.8999021058978167 }, "groups": { "assay_concept": "Fh" }, "target_z": -9.008358327089024 }
131.575325
-9.008358
0.100098
0.899902
null
true
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(B)
train
88a5e0f9aa0786951a88be4559a67338717fa1784b6b204a16039560f83d653b
ccfdf469b04bbb63084d8437dbf9ccf1b5a36e90be3eb1718386d7ddc39d2e43
O=C1CC=Cc2nc3ccccc3nc21
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
2d074ca8083c43b04d35daadfb6a8d4c2011077e2259d4df6b5bed4626843f1c
ext_31
ext_26
018fea87d7b6bd8e03fa0048a1f6207979d3f73092a9a220c934293cd9dffee2
b0ab15c33f05072f7daf6150db27aed90fe6c5f57af6d3ff8a6cd4603e75386e
{ "transfer": 0.13940962903015508, "nontransfer": 0.8605903709698449 }
{ "soft_targets": { "(A)": 0.13940962903015508, "(B)": 0.8605903709698449 }, "groups": { "assay_concept": "Fh" }, "target_z": -2.9600847575586484 }
76.805092
-2.960085
0.13941
0.86059
null
true
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(A)
train
88a5e0f9aa0786951a88be4559a67338717fa1784b6b204a16039560f83d653b
59fdf17e637dff02e39910ee28ffb6e1d10d77a2b225080a06daba816d3828f5
O=C1CC=Cc2nc3ccccc3nc21
CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
ab189668406aa09bffa686118794b881bc9e64a7469e2ed0374c11fea5dea38b
ext_31
ext_1
018fea87d7b6bd8e03fa0048a1f6207979d3f73092a9a220c934293cd9dffee2
b03e434cb7abb825a097096e7706cb9b9ce2b00891272031b8ca1c6240691cdc
{ "transfer": 0.7736350609700521, "nontransfer": 0.22636493902994792 }
{ "soft_targets": { "(A)": 0.7736350609700521, "(B)": 0.22636493902994792 }, "groups": { "assay_concept": "Fh" }, "target_z": 1.6735144495639205 }
34.845465
1.673514
0.773635
0.226365
null
false
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(A)
train
88a5e0f9aa0786951a88be4559a67338717fa1784b6b204a16039560f83d653b
913960a7324a525b3999f08a8639783b516e9bed8cd26ac127a53bbe4ee197ef
O=C1CC=Cc2nc3ccccc3nc21
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
97a7fc947ac711a8d8a2dffde94d3748ab79aaff9aed211e258f9952b9f48695
ext_31
ext_7
018fea87d7b6bd8e03fa0048a1f6207979d3f73092a9a220c934293cd9dffee2
798fbef5a453fa0a4697453fdc3dbb33e94fe2492dcb8338753fec75617bc24f
{ "transfer": 0.8965368257344831, "nontransfer": 0.10346317426551688 }
{ "soft_targets": { "(A)": 0.8965368257344831, "(B)": 0.10346317426551688 }, "groups": { "assay_concept": "Fh" }, "target_z": 5.438087776446507 }
0.755314
5.438088
0.896537
0.103463
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
1a84d822fb1bae4574185aac93326ab4005dc379a036f6c7e5f8a5336335f458
a17243d90ee44338a54b7584c5e87c7ae42284de70f78886bcfdd63344f7569d
Cc1c(Oc2ccc(Cl)cc2)c2ccc(C(F)(F)F)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1
CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
5648e530177a504833cb864581b4f967f9907b38423768f1149dba7616a8d854
152722
103849
00008c40a47fd98d8c17804114f2bdbc976d9d08c939ee61568ffe78e01bdd20
5ddc095f9b07f64c56e31c293a72eadeb2bba6ce3526e754f172713fac40b7e3
{ "transfer": 0.10011264348128827, "nontransfer": 0.8998873565187118 }
{ "soft_targets": { "(A)": 0.10011264348128827, "(B)": 0.8998873565187118 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -8.867998394128982 }
150.9
-8.867998
0.100113
0.899887
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
1a84d822fb1bae4574185aac93326ab4005dc379a036f6c7e5f8a5336335f458
3a561b570881fd4a7241951d5b8b84ed8bcda412deeb9e4343f6088f6eab3e4c
Cc1c(Oc2ccc(Cl)cc2)c2ccc(C(F)(F)F)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1
CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1F
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
7b1d8c91b9e2485b1c66179ca21e5a041d2eb5e41804c10cc8b697e9f0312aaa
152722
87645
00008c40a47fd98d8c17804114f2bdbc976d9d08c939ee61568ffe78e01bdd20
a8056741049cc27c74806e40129f618c741bf5570ec9d9ef9cc1d2488c427fd7
{ "transfer": 0.10169936804164391, "nontransfer": 0.8983006319583561 }
{ "soft_targets": { "(A)": 0.10169936804164391, "(B)": 0.8983006319583561 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -6.152228816541415 }
120
-6.152229
0.101699
0.898301
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
1a84d822fb1bae4574185aac93326ab4005dc379a036f6c7e5f8a5336335f458
f1f62b33ac5b2a9fc4271e65458310c88b3e4332c8be0cc82156231062331074
Cc1c(Oc2ccc(Cl)cc2)c2ccc(C(F)(F)F)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1
Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
b87c9d31ad441bcff0e5037ec8b359e6f78103a69743d1cbf130b88debd3d2c3
152722
161201
00008c40a47fd98d8c17804114f2bdbc976d9d08c939ee61568ffe78e01bdd20
23d353bcf709a53866d190bd450d176608e59ce732d1ab79e6d53339ac246288
{ "transfer": 0.24145430210432964, "nontransfer": 0.7585456978956704 }
{ "soft_targets": { "(A)": 0.24145430210432964, "(B)": 0.7585456978956704 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -1.5380572041353537 }
67.5
-1.538057
0.241454
0.758546
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
1a84d822fb1bae4574185aac93326ab4005dc379a036f6c7e5f8a5336335f458
336724118f29fe810792c3fb2ae503e028d577dc2953093fdebaffdd2c8c6372
Cc1c(Oc2ccc(Cl)cc2)c2ccc(C(F)(F)F)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1
COc1ccc(-c2ncc3c(c2F)-c2[nH]c4c(c2CC3)C(=O)NCC42CN(C)C2)cc1F
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
bf749cebd5608ec2d667015663d48aa27dae4034464fcb3f0c04ea190f5aec4d
152722
50606
00008c40a47fd98d8c17804114f2bdbc976d9d08c939ee61568ffe78e01bdd20
a5b18599427e2f7142f0954da60ce7b1d97076552795ecb3b5a8b5b113fac4a5
{ "transfer": 0.8878828391418382, "nontransfer": 0.11211716085816181 }
{ "soft_targets": { "(A)": 0.8878828391418382, "(B)": 0.11211716085816181 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 4.174726696938817 }
2.5
4.174727
0.887883
0.112117
null
true
null
null
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 3-fold of each other, and considered not to transfer once they are 10-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO</SMILE...
(A)
train
e677aac48fcb7a6cb7346c0383b76eecc14745a45da86ceca3caacd04459aadc
1fc9dba96d2fd32a9e09f3639ddb448d1fcc57f071b22d2eb6bc7af29019b36f
N[C@@H](Cc1ccccc1)C(=O)O
O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
bioavailability_ma/intestinal_effective_permeability/peff_unspecified/v2
Fa
31494098c8ba84dfc9dbb91bdd002fe20ffc49dc7724130357d9c4aacec54e8b
ext_2
ext_4
28714c926d999af91bbe0c803b4b080c64e500b90244e415c46442a2ea5ed5d5
53287e9c201c458e80499a3f5387f942d968d84cb110b8eefcc76b501b06735c
{ "transfer": 0.8603171832704691, "nontransfer": 0.13968281672953087 }
{ "soft_targets": { "(A)": 0.8603171832704691, "(B)": 0.13968281672953087 }, "groups": { "assay_concept": "Fa" }, "target_z": 2.95281742659953 }
29.762276
2.952817
0.860317
0.139683
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
37a9fac35ced19d8955ba9cb1305f8add550a0d164b75b1a8df0329d58dd920c
6a5c26b7ba1533e6d6a7832d4c3e71bc205c055512157f13ff4682df263796dc
C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
0be7e269374e1d00f931a10ba0f10f66065ae1a23317755be46423e58127d37c
138794
45211
0003f25addebfd8e3100cfd6158cfb2a7a061ff228b4109703f734046a4c9289
3de81ae40b3ec92c85c8a5cb13dd632d5f2f02cf61bdbccfeb3388aafa88427c
{ "transfer": 0.1000000003343889, "nontransfer": 0.8999999996656111 }
{ "soft_targets": { "(A)": 0.1000000003343889, "(B)": 0.8999999996656111 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -21.595572919518936 }
245.559038
-21.595573
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
37a9fac35ced19d8955ba9cb1305f8add550a0d164b75b1a8df0329d58dd920c
c4b949ab56a7586968723b0bf1ee2217224d07165fe3a5c35260f13f992a7a1d
C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
7508f36f59a3efc85086ed6c43cf5f0c0131c872ef6e55e6394e8ace6581637b
138794
19309
0003f25addebfd8e3100cfd6158cfb2a7a061ff228b4109703f734046a4c9289
f8e4910c17cb1e21fc80b70722a63ce8ad651b52cfaf3d7efa17a0a58a38d07b
{ "transfer": 0.12160755047058884, "nontransfer": 0.8783924495294112 }
{ "soft_targets": { "(A)": 0.12160755047058884, "(B)": 0.8783924495294112 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -3.5841880184046158 }
82.456669
-3.584188
0.121608
0.878392
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
37a9fac35ced19d8955ba9cb1305f8add550a0d164b75b1a8df0329d58dd920c
ecebb0e1942efd13f7a04f257056b3d96a54e7b1d24269cdd6238580d69021dd
C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
fc9c47eb0cd1bf8a4e185e9df2fd7c07e5dc98bba72e98fc4f3fd37b5d495b4d
138794
106937
0003f25addebfd8e3100cfd6158cfb2a7a061ff228b4109703f734046a4c9289
1b8a5018ae70d087bd0776abe302efb07100104869dfe339e894758858141e23
{ "transfer": 0.4784904448865066, "nontransfer": 0.5215095551134934 }
{ "soft_targets": { "(A)": 0.4784904448865066, "(B)": 0.5215095551134934 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -0.10765161862010429 }
50.974841
-0.107652
0.47849
0.52151
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(A)
train
37a9fac35ced19d8955ba9cb1305f8add550a0d164b75b1a8df0329d58dd920c
bae1ab61aa0be052166f2dce443f70a88944df1f4758f2f368fbe0a9c938cafe
C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
698c88a04e12f379469e429ab8803c17d2579eac8089ad299adcb850b3b5cfce
138794
20752
0003f25addebfd8e3100cfd6158cfb2a7a061ff228b4109703f734046a4c9289
2e24a742f11733f8ec3cab6845f15ac5ddfadbffdd2e6e819a3bf1537e4c6f3e
{ "transfer": 0.8911420173654468, "nontransfer": 0.10885798263455315 }
{ "soft_targets": { "(A)": 0.8911420173654468, "(B)": 0.10885798263455315 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 4.492158448127391 }
9.321191
4.492158
0.891142
0.108858
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 1.5-fold of each other, and considered not to transfer once they are 3-fold or more apart. Molecule A (retrieved measurement) - <SMILES>CC(=CC(=O)O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C<...
(A)
train
9160e3ff4f8def60cc6d6ef136263261eac98dd31617ccfb5109c6317752a591
78156c24ebfbb223b9633de0265eec7e21a798af41e9fdb2683be3c2bf88424a
Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21
CC(=CC(=O)O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
bioavailability_ma/tmax/tmax/v2
oral_exposure
c0d1af94bb1d01030c734686b0d2495b1bb6de9ee051ba0d46f175c3555bce57
ext_14
ext_13
51b175a4689676d09ffb4c3d515ed639b65074a6a57b2fdff0a63f5e807f54fc
6b2c5d7b4469107261e436226854b33deebab7bf1de0302eb80c6b781ac7b1d1
{ "transfer": 0.8729653775327487, "nontransfer": 0.12703462246725128 }
{ "soft_targets": { "(A)": 0.8729653775327487, "(B)": 0.12703462246725128 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": 3.3531158997023014 }
13.864688
3.353116
0.872965
0.127035
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 1.5-fold of each other, and considered not to transfer once they are 3-fold or more apart. Molecule A (retrieved measurement) - <SMILES>CC(=CC(=O)O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C<...
(A)
train
9160e3ff4f8def60cc6d6ef136263261eac98dd31617ccfb5109c6317752a591
653e12dfff1414c4dfea0b1491097c0dda9ada22ada8895ad65122625e7f88eb
Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21
CC(=CC(=O)O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
bioavailability_ma/tmax/tmax/v2
oral_exposure
7e956546ba0217b53bbe4660166c1939550c6ab717a64ce1bb3063aff0ec62b3
ext_14
ext_12
51b175a4689676d09ffb4c3d515ed639b65074a6a57b2fdff0a63f5e807f54fc
ad6d4544b88bddf505ab8e765ee1d4e025d901bb125f8ba68b246bec09f05215
{ "transfer": 0.8767691791980844, "nontransfer": 0.12323082080191561 }
{ "soft_targets": { "(A)": 0.8767691791980844, "(B)": 0.12323082080191561 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": 3.509663359704597 }
12.33045
3.509663
0.876769
0.123231
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
fdb16dab56135c0e162bea3a4c30b436ade4627ab7607d9171f0a249a0da06fc
2b4f4807648fecd58e1a7ae2e50890c91fa180cb620d77cd0c7a39d94ce5f796
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2
COc1ccc2cc1Oc1ccc(cc1)CC1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1C(C2)N(C)CC3
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
ef88334d02fa6bdadfaf7da2945655d664b012fb3e775b82c2426b30ac6289a9
35556
41408
0000b8a40eb9ce5a692245a34e204d22e9eee0385c0353280612d41a0fd8479b
5968cfa515483abd1aef80f989de3881fe657b0a5ac5970879c18151b9e5a1ef
{ "transfer": 0.10000002382205934, "nontransfer": 0.8999999761779407 }
{ "soft_targets": { "(A)": 0.10000002382205934, "(B)": 0.8999999761779407 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -17.329510241450762 }
247.175
-17.32951
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
fdb16dab56135c0e162bea3a4c30b436ade4627ab7607d9171f0a249a0da06fc
f3a3fbf338715aa1a0a808306fd2f818902d7ac5e30d4cee4aaa141c1dad1a69
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2
Cc1ccc(-n2[nH]c(C)c(N=Nc3cccc(-c4cccc(C(=O)O)c4)c3O)c2=O)cc1C.NCCO.NCCO
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
7d82ca3f0ec0de8f979236b24ade367ec25b88c98a9324c8ac6b335733bf6fb5
35556
125098
0000b8a40eb9ce5a692245a34e204d22e9eee0385c0353280612d41a0fd8479b
defbc14acbace7714760ca42fd95dcd0d8db1d954f68c32e7f310a09de7a3967
{ "transfer": 0.10074311825802337, "nontransfer": 0.8992568817419766 }
{ "soft_targets": { "(A)": 0.10074311825802337, "(B)": 0.8992568817419766 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -6.98058248219717 }
129.425
-6.980582
0.100743
0.899257
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
fdb16dab56135c0e162bea3a4c30b436ade4627ab7607d9171f0a249a0da06fc
936e9c3ba40bf3f24615795b0864bc6239df0b3ef2ab0a9829b35be3688538a4
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2
CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
ed1f2a2b55efb30ee67e1162729d28b8f3819d1de6db7f82db8b28a5736e8633
35556
153614
0000b8a40eb9ce5a692245a34e204d22e9eee0385c0353280612d41a0fd8479b
17660fca261008d57a1eab1a62fc0718bd1d42d2dfe828730f48abb23c0e8a60
{ "transfer": 0.5537251163487329, "nontransfer": 0.4462748836512671 }
{ "soft_targets": { "(A)": 0.5537251163487329, "(B)": 0.4462748836512671 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 0.27025862301235526 }
46.925
0.270259
0.553725
0.446275
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
fdb16dab56135c0e162bea3a4c30b436ade4627ab7607d9171f0a249a0da06fc
ed2c9e8d319b192ee87f62951cbba2a54ffdb7854466a9fd811805a08092b87b
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
643bffc335428229dcef2f45ecd70dd383ebaffd69b54fbcde40cd3ce6659fb9
35556
23060
0000b8a40eb9ce5a692245a34e204d22e9eee0385c0353280612d41a0fd8479b
fd3e257a3675ea1af640b335fb760bfbdb42de6e5dcdb7fdca208097a44f7731
{ "transfer": 0.8896777308889374, "nontransfer": 0.11032226911106258 }
{ "soft_targets": { "(A)": 0.8896777308889374, "(B)": 0.11032226911106258 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 4.337321315661698 }
0.65
4.337321
0.889678
0.110322
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>NCC(=O)N[C@@H](CO)C(=O)O</SMILES> - measured pr...
(A)
train
96ca8a7ce7ec36563e4649133eb40b4fffaa6d9522329a294f31d95bdb666374
a76f6f8dd67fb3c67f785893b15a2213484891268c146f21d43990bf0679c484
N=C(N)NCCC[C@H](N)C(=O)NCC(=O)O
NCC(=O)N[C@@H](CO)C(=O)O
bioavailability_ma/auclast/auc_exposure/v2
oral_exposure
7cc9931fa66b0e193a94a48a8d635820515032a98623691ee10f4d782c88dc2d
ext_62
ext_65
1adb0c06987490698572ed3a7151c64bc4ed6d43f0a2e31b742c13bc9878b6e6
a9214545d71066ec4fc2ebf826f78c7c268e17bff785d9a113d5f6bbbe671cf4
{ "transfer": 0.8188712585765756, "nontransfer": 0.1811287414234244 }
{ "soft_targets": { "(A)": 0.8188712585765756, "(B)": 0.1811287414234244 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": 2.1816449922650634 }
30.244081
2.181645
0.818871
0.181129
null
false
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(B)
train
57d72a60296b5c388c3b35fd84f733e728d79d7def6c6360089898523106785c
027cfa8e3ac26b5d0886655980b49e6c0148ccf7c56430270dd8a6ec7cae7213
Cn1c(=O)c2c(ncn2C)n(C)c1=O
CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
0b1c0c2e0bd13f02288307223877113cfaeb2db1192a14db498eaffaf6fbc86f
ext_22
ext_1
42715c3aa396ecfde3e273a9c2262ce758f5ea8bdaa8c6eae81a037339501f7d
f158073ca07a0f32f32ad53fd742fac1ca8f2a59e1d3da1b29a2a161f4ba0dc8
{ "transfer": 0.10225567133512715, "nontransfer": 0.8977443286648729 }
{ "soft_targets": { "(A)": 0.10225567133512715, "(B)": 0.8977443286648729 }, "groups": { "assay_concept": "Fh" }, "target_z": -5.86834051773096 }
103.140846
-5.868341
0.102256
0.897744
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
5f61c41facb52633e97b1e6b8ca35df413b5cfb615acbb0823d61035c06454ad
e9104c8c21ae9056b6d3d628e027ff45672ed81739218bb46117f7ffd5790966
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
a32525e0d882f6929b05398816987645a40e3bb2bf072d3d0c0e815ed3bac088
124161
126348
000ef959250d5a9701265039450caf71f187ab021c668493135eac1eb88c5242
dedf850789a0614cf2afadee585b56345af30d0a043cfdb37b140b782e94ef3b
{ "transfer": 0.100078564942113, "nontransfer": 0.899921435057887 }
{ "soft_targets": { "(A)": 0.100078564942113, "(B)": 0.899921435057887 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -9.228343224812122 }
155
-9.228343
0.100079
0.899921
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
5f61c41facb52633e97b1e6b8ca35df413b5cfb615acbb0823d61035c06454ad
83d65c30e8259913fcbf6a2f5643fb4d85821c7d4e38743c3d5484265022b383
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
943519b884511cbad351f85dfcfacee2d7ec419e929232429ee9135f451c83e8
124161
3292
000ef959250d5a9701265039450caf71f187ab021c668493135eac1eb88c5242
253abcdbede7620975e588e8e7d2cef4e8d2c49d9904a81ac76750ab71decbf5
{ "transfer": 0.19141881686056383, "nontransfer": 0.8085811831394362 }
{ "soft_targets": { "(A)": 0.19141881686056383, "(B)": 0.8085811831394362 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -2.0478133060773565 }
73.3
-2.047813
0.191419
0.808581
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
5f61c41facb52633e97b1e6b8ca35df413b5cfb615acbb0823d61035c06454ad
9f45f03da32dde69a4d1259476123d9b6b2a33d1976c0012ad5112442b91c713
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
O=C[C@H](O)[C@@H](O)[C@H](O)CO
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
226d4c30ed4c4eb7440cced56dc3b744d66750c825bdfe884b7fb915c08a1c29
124161
158041
000ef959250d5a9701265039450caf71f187ab021c668493135eac1eb88c5242
fbc4d034fd34737ed376db0c789d600199afa737894ef138353d00436e4eba2a
{ "transfer": 0.7660584525385515, "nontransfer": 0.23394154746144846 }
{ "soft_targets": { "(A)": 0.7660584525385515, "(B)": 0.23394154746144846 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 1.6039739414554404 }
31.75
1.603974
0.766058
0.233942
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
5f61c41facb52633e97b1e6b8ca35df413b5cfb615acbb0823d61035c06454ad
2f6f2fd720d0f5393d614303433aae62e8830f665bb8cbd3238ec50a661794f4
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(OC)c2F)cc(SCC)n1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
141a5a8645a06c69142740ecf75da3355baca27f7b2e061f4ce95bf5ec2c0135
124161
163276
000ef959250d5a9701265039450caf71f187ab021c668493135eac1eb88c5242
b75364f7b305f65006e2986596afe0fb3e3a3db2aa7072f0935f79d183d6fc2f
{ "transfer": 0.8647173318395287, "nontransfer": 0.1352826681604713 }
{ "soft_targets": { "(A)": 0.8647173318395287, "(B)": 0.1352826681604713 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 3.0761144082707075 }
15
3.076114
0.864717
0.135283
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>N=C(N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(=O...
(B)
train
cc15f9ccecb4c37df5415d31a3ce19dba1fed3f37a448e78150ef511a6e54ec8
b4ecdb33d6c2135c5a2cd85452ee4dee81db2c878baeaa0ccec4d59f8d49b817
S=C=NCCc1ccccc1
N=C(N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(=O)O)C2CCCCC2)cc1
bioavailability_ma/auc/auc_exposure/v2
oral_exposure
c586a8d68391649f07d8dc5bbe77c6bc3e02b76aafd0c3cbaa5ebd7db0009313
ext_12
ext_57
12f6118806b8dbc568f0522facae830d1416fabc76614559cf47b9c1382eecf4
16115c186ccb94dcdd50618cd4b24d236f7d9f26c50af70798da9e0bb2260d88
{ "transfer": 0.10002614584554066, "nontransfer": 0.8999738541544593 }
{ "soft_targets": { "(A)": 0.10002614584554066, "(B)": 0.8999738541544593 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -10.328644016257481 }
143.531192
-10.328644
0.100026
0.899974
null
true
null
null
You are comparing two molecules for a gut-wall availability / intestinal efflux transport (Fg) assay. Values reported under different assay systems (e.g. Caco-2 vs. MDCK, or different transporter overexpression lines) are not directly comparable, so both records below share the same assay system by construction. Two m...
(A)
train
51e99c7380053ef9712f7790dd6cc3e948d9babbcb74971cee1025c778e9edf1
444691be7f1c7b49f102d9a4b35d661db746f810912f51f762d3dccf2f077f60
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C1C
bioavailability_ma/bidirectional_permeability/papp_unspecified/v2
Fg
a11710125d600da35cee78cd6f7c73d9297b25b20b26ef6b1110779cd2afec8a
ext_1
ext_15
01a37e020776ace7a0b0f69ef418bf6b461569d0e1443105eff2800d8453682b
886b5c7de3f1c044dc5c457b73f7b6b4403557aa2d9b624b9402738b8a4864ae
{ "transfer": 0.8520442555681716, "nontransfer": 0.14795574443182835 }
{ "soft_targets": { "(A)": 0.8520442555681716, "(B)": 0.14795574443182835 }, "groups": { "assay_concept": "Fg" }, "target_z": 2.752516578098631 }
31.594135
2.752517
0.852044
0.147956
null
true
null
null
You are comparing two molecules for a gut-wall availability / intestinal efflux transport (Fg) assay. Values reported under different assay systems (e.g. Caco-2 vs. MDCK, or different transporter overexpression lines) are not directly comparable, so both records below share the same assay system by construction. Two m...
(A)
train
51e99c7380053ef9712f7790dd6cc3e948d9babbcb74971cee1025c778e9edf1
0c210f7b101234dfa04ac175f2663349862992c42082bd48f3bbd3f28a23dd3a
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
bioavailability_ma/bidirectional_permeability/papp_unspecified/v2
Fg
aa947857cf0ac7f9f1b7e4e43f91a08778f6d9fcd79cdbc5e61eb6f8aece1fd6
ext_1
ext_48
01a37e020776ace7a0b0f69ef418bf6b461569d0e1443105eff2800d8453682b
cdce07c5e45c655d8bc41491cc6d4faee23d7e750453f1768845a9a27b741f6a
{ "transfer": 0.8883285641375978, "nontransfer": 0.11167143586240225 }
{ "soft_targets": { "(A)": 0.8883285641375978, "(B)": 0.11167143586240225 }, "groups": { "assay_concept": "Fg" }, "target_z": 4.212770485023799 }
18.239328
4.21277
0.888329
0.111671
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
ab176e6de6530b9c7b1eaf49bf651bd82c62186bd2d4b21a0852d1e10289066e
ea4940f4e6f9aa60fa41ceb073c8956c3f9c3db7766a59f61826a800dfdbe073
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
301d880dd492d8f6b1c915ae3594feb19baeef1d0f419eebbc6be7e9feea45fa
80046
133175
004b1bfac982499ccd0ed4bcdf883a1a70e1ed3ecbedaff59ff29a9e9178bfbd
4d67d6b2b3c321c5f1f5786f71415559cbc1e2a6a85ac94707c34fb8c7397c62
{ "transfer": 0.1000000097271508, "nontransfer": 0.8999999902728492 }
{ "soft_targets": { "(A)": 0.1000000097271508, "(B)": 0.8999999902728492 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -18.22520124674245 }
215.038586
-18.225201
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(A)
train
ab176e6de6530b9c7b1eaf49bf651bd82c62186bd2d4b21a0852d1e10289066e
2d824b29d3c88625140150a31e806d180130d48e1b7e3c755425b896635485f4
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
f0e490febda2c926313a3a7c19fe01daf2bc41f6f27131d262fb3324e7a85e9a
80046
14745
004b1bfac982499ccd0ed4bcdf883a1a70e1ed3ecbedaff59ff29a9e9178bfbd
55e59d155ff410e15f2154b72f0ae84ec8681c651f93b852b53c2fb253b10add
{ "transfer": 0.6343911401970679, "nontransfer": 0.3656088598029321 }
{ "soft_targets": { "(A)": 0.6343911401970679, "(B)": 0.3656088598029321 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 0.699103268374765 }
43.66926
0.699103
0.634391
0.365609
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(A)
train
ab176e6de6530b9c7b1eaf49bf651bd82c62186bd2d4b21a0852d1e10289066e
92384b73d90c1c09733cb566d107bf7ca33d8e34460e367e1bee1cbec5cdfd4c
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
e46d64a45f42f4667d31cdbaed702054c2b628d2411d5d0ea0e216c1ebf7a08e
80046
13332
004b1bfac982499ccd0ed4bcdf883a1a70e1ed3ecbedaff59ff29a9e9178bfbd
31c88bfadcfd1755ec29c4c0f4b0573ab536b3483b670bc1df4dbdb92f9a9d51
{ "transfer": 0.8954195631713175, "nontransfer": 0.10458043682868245 }
{ "soft_targets": { "(A)": 0.8954195631713175, "(B)": 0.10458043682868245 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 5.157075356839211 }
3.300026
5.157075
0.89542
0.10458
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(A)
train
ab176e6de6530b9c7b1eaf49bf651bd82c62186bd2d4b21a0852d1e10289066e
805231ca6d11774f52678b6ac39fbda25b7cbc1fbcf5e75e3877a11aafcdb70a
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
94e61685b2334ee2b3453d9ce304901d9f8cd4eb4039e39662fe3631d8235e08
80046
117755
004b1bfac982499ccd0ed4bcdf883a1a70e1ed3ecbedaff59ff29a9e9178bfbd
6e17e79be46dbc18de7f99f58caebddd84367ce5c9a155da53bbd0ad7c32cd55
{ "transfer": 0.8964352950323434, "nontransfer": 0.10356470496765657 }
{ "soft_targets": { "(A)": 0.8964352950323434, "(B)": 0.10356470496765657 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 5.409064597009411 }
1.018134
5.409065
0.896435
0.103565
null
true
null
null
You are comparing two molecules for a gut-wall availability / intestinal efflux transport (Fg) assay. Values reported under different assay systems (e.g. Caco-2 vs. MDCK, or different transporter overexpression lines) are not directly comparable, so both records below share the same assay system by construction. Two m...
(B)
train
f06ecdb289bb441e0ecd22541cc1a5c7d4f487ff0750d18ef9860b951b2ee210
99bc1c4ada609614617b52d5f360c87f11005617631711c2ff41c73615de4891
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1
bioavailability_ma/efflux_or_secretory_transport/directional_efflux_ratio_b_over_a/v2
Fg
39775d6e26d15ed52e6f21107475b0475b4e396d3937d676c3db55a71f88b1fe
ext_8
ext_11
259bcf034cff56f27fe2dcde02b9626bc7a41a923e78a90f5874acf1f4a2a5c3
f1c7acda95bc6260b560433e147f4ee76c5af6ce9efc1987c43475e2e336821d
{ "transfer": 0.10000000000283922, "nontransfer": 0.8999999999971607 }
{ "soft_targets": { "(A)": 0.10000000000283922, "(B)": 0.8999999999971607 }, "groups": { "assay_concept": "Fg" }, "target_z": -26.36434952456338 }
305.10974
-26.36435
0.1
0.9
null
true
null
null
You are comparing two molecules for a gut-wall availability / intestinal efflux transport (Fg) assay. Values reported under different assay systems (e.g. Caco-2 vs. MDCK, or different transporter overexpression lines) are not directly comparable, so both records below share the same assay system by construction. Two m...
(B)
train
f06ecdb289bb441e0ecd22541cc1a5c7d4f487ff0750d18ef9860b951b2ee210
3be7af775a2189b8078940501c2fd002e9d7ef12619e60b0ec54515306521c43
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1
bioavailability_ma/efflux_or_secretory_transport/directional_efflux_ratio_b_over_a/v2
Fg
286eb3954d86de886b0fa5b841b1e7dd757395d138eb714d22a7be5a252f0702
ext_8
ext_10
259bcf034cff56f27fe2dcde02b9626bc7a41a923e78a90f5874acf1f4a2a5c3
e70a5405a8b3699b89deb0da9daa899aadf154fe77c0c94c3036481611178c26
{ "transfer": 0.10000000113147003, "nontransfer": 0.89999999886853 }
{ "soft_targets": { "(A)": 0.10000000113147003, "(B)": 0.89999999886853 }, "groups": { "assay_concept": "Fg" }, "target_z": -20.376604591029285 }
246.427041
-20.376605
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
9ffcc2805e94ab1fa7379f61ec89278ae1f4256357ca1ad0a049da6eae175933
0f02205ce2b48b875361f3f02541c25e45d0406bead7880a2936dbe1912eef8f
CC(=O)Oc1ccccc1C(=O)O
CCOC(=O)OCC
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
08021f0619af5e2301369f752e5bed4117a3e75325f6f9e62487ce74d9f6f141
160858
73503
0001fab5efd65eb00c6d0a88b2b9759e5c1b07cef694c7f1eebfa5fbe27c2506
04e59de5161882a1c77ac7102a7a23f8a369ba93b1fa62c8ec506bf645f7f713
{ "transfer": 0.10000230039537553, "nontransfer": 0.8999976996046245 }
{ "soft_targets": { "(A)": 0.10000230039537553, "(B)": 0.8999976996046245 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -12.759283120591428 }
195.175
-12.759283
0.100002
0.899998
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
9ffcc2805e94ab1fa7379f61ec89278ae1f4256357ca1ad0a049da6eae175933
022d2bea9d4e549899e30a28fa4320b7c49e8677d11389a69397e59ab0f8b71d
CC(=O)Oc1ccccc1C(=O)O
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
9f06b64468590cb18e746e533acf6691303907083f44fc41b10cf0157dfeab9c
160858
50040
0001fab5efd65eb00c6d0a88b2b9759e5c1b07cef694c7f1eebfa5fbe27c2506
6fbb44e98bde1ce2a1d94dad0c8e312c0fe606b17ff172e4f0402362cacf79d4
{ "transfer": 0.47410899922699257, "nontransfer": 0.5258910007730074 }
{ "soft_targets": { "(A)": 0.47410899922699257, "(B)": 0.5258910007730074 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -0.12963625006283647 }
51.475
-0.129636
0.474109
0.525891
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
9ffcc2805e94ab1fa7379f61ec89278ae1f4256357ca1ad0a049da6eae175933
23abece684e610e04832b5098d15975e042a376fe704a3c23e25a4120376f96a
CC(=O)Oc1ccccc1C(=O)O
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
c734b803943fbc67de2a86e5ef5b7553764f75e43b8e58a95939293b978be60b
160858
48507
0001fab5efd65eb00c6d0a88b2b9759e5c1b07cef694c7f1eebfa5fbe27c2506
e86d1aed5ace5b3a9ef9664b1eccbbafab6c39f92adec7835e7502a2e65e2da2
{ "transfer": 0.7860443051953077, "nontransfer": 0.21395569480469234 }
{ "soft_targets": { "(A)": 0.7860443051953077, "(B)": 0.21395569480469234 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 1.7951324796836916 }
29.575
1.795132
0.786044
0.213956
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
9ffcc2805e94ab1fa7379f61ec89278ae1f4256357ca1ad0a049da6eae175933
3a62610259905a7a4e8a7339ad47d0eaa91d9b0ea66c626f869a02be6cac61b6
CC(=O)Oc1ccccc1C(=O)O
CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
7c77cd3eed1e9cd629de8f748ee7a241f0904558379bc407be6160912cc0fa8a
160858
120823
0001fab5efd65eb00c6d0a88b2b9759e5c1b07cef694c7f1eebfa5fbe27c2506
10407a9cda169501d614fa9d940c6157af1a2042aa0d1aafc6c78096f1be5306
{ "transfer": 0.8760490213761967, "nontransfer": 0.12395097862380333 }
{ "soft_targets": { "(A)": 0.8760490213761967, "(B)": 0.12395097862380333 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 3.4782065059232354 }
10.425
3.478207
0.876049
0.123951
null
true
null
null
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 3-fold of each other, and considered not to transfer once they are 10-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO</SMILE...
(B)
train
7d0fc99795fd535e8b8ef644f0a4aa58c428518bee4b37dfd7f913011bc64956
7a154a1ff7b27f1c8af08a867fbb1587c922f03019cafeedfefd64b106a4c063
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O
O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
bioavailability_ma/intestinal_effective_permeability/peff_unspecified/v2
Fa
7489eee5331e2561605eb1e124ef47c4396fa0483afc16189e2a35dbd8351b42
ext_27
ext_2
5763e0eb2d03b4e31ec198530b4679f77cee879b08b8f62b92d86c9382840267
95fc737e3623cee6fb40722e06aab22f60f6de080f936aa7181c63948f274b3d
{ "transfer": 0.140565196058778, "nontransfer": 0.859434803941222 }
{ "soft_targets": { "(A)": 0.140565196058778, "(B)": 0.859434803941222 }, "groups": { "assay_concept": "Fa" }, "target_z": -2.9296640185534057 }
83.560731
-2.929664
0.140565
0.859435
null
true
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(A)
train
bb1d0835d5346913b85de6514da40d98d378ecb0d43c178cd85573adbe68aca7
8d24b5f83d82709d49d616b1512445b4e6009a8bc20180ceb63ae6367f963b7e
CCCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1
CCN(CC)CCn1c(Cc2ccc(OC(C)C)cc2)nc2cc([N+](=O)[O-])ccc21
bioavailability_ma/substrate_depletion/matched_time_percent_remaining__time_1800s/v2
Fh
e1176fad97c43e86783c935a1e103327091ff5fdbe3b63fa066363aa0869ea28
ext_40
ext_39
b1c66d87d4a54184a790b60105a206f29090bc52e4861db84808d586cb64f9f5
e14408c2033f1ea7cc59917f96f1e5619be02e56e806d854e1f5decded397c09
{ "transfer": 0.82, "nontransfer": 0.18000000000000005 }
{ "soft_targets": { "(A)": 0.82, "(B)": 0.18000000000000005 }, "groups": { "assay_concept": "Fh" }, "target_z": 2.1972245773362196 }
25
2.197225
0.82
0.18
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
4f23d7e0664e798a857422e1ca9c1800c50e750199d320b45399f3d63b3888a2
1b435c2880e8accb4dc4754ae7d325970053d9a81a36cf14ed2cd43cddd5a5a9
CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1
CN(CCc1ccc(Br)cc1)C1CCN(c2nc(N)n[nH]2)CC1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
f3e860f9d320bb3f98fd5b08224602f68099dbea66bf7d8d7041f90c755419f7
157270
139020
0001f5b5dcf020c8d50898f32867244506fca89199bca417de0348445aaf7d0d
d3f2dae0d4c51dfe0941df79695ae26a450e49ffbcf212d2f512968e6c24549c
{ "transfer": 0.10000016726009153, "nontransfer": 0.8999998327399085 }
{ "soft_targets": { "(A)": 0.10000016726009153, "(B)": 0.8999998327399085 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -15.380572041353537 }
225
-15.380572
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
4f23d7e0664e798a857422e1ca9c1800c50e750199d320b45399f3d63b3888a2
c0cdf6f06303b45860a7645c2d4e19b0cab03b6208d338ad550a851919bf3cd4
CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1
CCCN(CCC)C1CCc2ccc3[nH]cc(C=O)c3c2C1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
0da989eae1cb0841340fd6a4e0ad2b305b9eb4e501931f5a92c6edbb27724956
157270
146501
0001f5b5dcf020c8d50898f32867244506fca89199bca417de0348445aaf7d0d
4b81fa19b1c0e0ddf7a087688c5af1d46276074079fde69077df35e7100a7f47
{ "transfer": 0.10006306856609548, "nontransfer": 0.8999369314339045 }
{ "soft_targets": { "(A)": 0.10006306856609548, "(B)": 0.8999369314339045 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -9.448065682545744 }
157.5
-9.448066
0.100063
0.899937
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
4f23d7e0664e798a857422e1ca9c1800c50e750199d320b45399f3d63b3888a2
e1aabb15a5923ba0d19e9ee67fb87a4e46e761f4068656c5367797c42386a419
CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1
O=C(NOCC1CC1)c1ccc(F)c(F)c1N(Cl)c1ccc(I)cc1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
f01a8bc432a10f7b7fbf8b23e7022287c61b59e654a5f34227353f85bb99f154
157270
145235
0001f5b5dcf020c8d50898f32867244506fca89199bca417de0348445aaf7d0d
e83140796206b2fa16994952d39d9a2d0a00631c9ec0801d4a36d25be77d836f
{ "transfer": 0.5307006462132017, "nontransfer": 0.4692993537867983 }
{ "soft_targets": { "(A)": 0.5307006462132017, "(B)": 0.4692993537867983 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 0.15380572041353535 }
48.25
0.153806
0.530701
0.469299
null
false
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
4f23d7e0664e798a857422e1ca9c1800c50e750199d320b45399f3d63b3888a2
a7fe60804855ab686101872f03637edc7ac45bca8c6f568f785fda41f06844ef
CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1
C#CCN(C)[C@H](C)Cc1ccccc1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
3fcf7e06d411b5f5d063ef754c81164c3905cc10feca13bccae8b44e68ba4987
157270
49834
0001f5b5dcf020c8d50898f32867244506fca89199bca417de0348445aaf7d0d
2a4a95829ba7fae42785db53214d2ea52e8dc14b2f8e833b65ed4f6b2eeef3b5
{ "transfer": 0.8878828391418382, "nontransfer": 0.11211716085816181 }
{ "soft_targets": { "(A)": 0.8878828391418382, "(B)": 0.11211716085816181 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 4.174726696938817 }
2.5
4.174727
0.887883
0.112117
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 1.5-fold of each other, and considered not to transfer once they are 3-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1...
(B)
train
fac211b5ea95c92b2e09d678fda5f6c09606b512a40849f9253f44a471799b43
bbb87323efd16ddf44e84ed127539890054db269294d108bae13086b4db68d31
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
bioavailability_ma/tmax/tmax/v2
oral_exposure
79868a4a9cf4364121568f3a689966f5a94d30670c69c9294a740bb6d9b65086
ext_36
ext_23
0dfa642cabd1d22b1627a58c2a55a8857cffea06ce0f61930fcf55d7b2c83918
714d243bd7280b7cd42b2d991ee69788fc356d56d8a840b467822f9230bd46d4
{ "transfer": 0.10000005422153556, "nontransfer": 0.8999999457784644 }
{ "soft_targets": { "(A)": 0.10000005422153556, "(B)": 0.8999999457784644 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -16.50704405337494 }
208.503539
-16.507044
0.1
0.9
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 1.5-fold of each other, and considered not to transfer once they are 3-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1...
(B)
train
fac211b5ea95c92b2e09d678fda5f6c09606b512a40849f9253f44a471799b43
7f4a0bd4b15fc31adcf16cdde4d43c7adf79c055ca2c8fc0438ecbf92415e7cf
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
bioavailability_ma/tmax/tmax/v2
oral_exposure
3562ead3e91cdeba859c65df9204ad5809482ee5ab7c9f573a5b49a0c8df1bc6
ext_36
ext_34
0dfa642cabd1d22b1627a58c2a55a8857cffea06ce0f61930fcf55d7b2c83918
75e2e429ce20e43adcda75692e99dce96159a39cb3f2f84cc6ae6da0f9529b0f
{ "transfer": 0.10004432280577522, "nontransfer": 0.8999556771942248 }
{ "soft_targets": { "(A)": 0.10004432280577522, "(B)": 0.8999556771942248 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -9.800812253970337 }
142.779333
-9.800812
0.100044
0.899956
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 1.5-fold of each other, and considered not to transfer once they are 3-fold or more apart. Molecule A (retrieved measurement) - <SMILES>C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC...
(B)
train
fac211b5ea95c92b2e09d678fda5f6c09606b512a40849f9253f44a471799b43
4f33cc6086afe230bb256852610fb729d7f2cfaf2637da8aab5a2e812e44f553
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2O
bioavailability_ma/tmax/tmax/v2
oral_exposure
63f459c2574816bfb75800845723531c0cb0935d4fbfc4fb89b785088a61a48b
ext_36
ext_72
0dfa642cabd1d22b1627a58c2a55a8857cffea06ce0f61930fcf55d7b2c83918
7154ad5edddf1237d752c0bb8993d732fe059f244496d87c53caa5c5d26edb0b
{ "transfer": 0.47028357590372716, "nontransfer": 0.5297164240962728 }
{ "soft_targets": { "(A)": 0.47028357590372716, "(B)": 0.5297164240962728 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -0.14885637884108172 }
48.185654
-0.148856
0.470284
0.529716
null
false
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(B)
train
7e9ed102f5e6f687fd223cc7a87f60afe6f892a3e96fcf4e21b88167bbd7bab1
2074887b50e779897db6010437a151a6426111ac81f9627f24867f18e3767ddf
Cn1c(=O)c2c(ncn2C)n(C)c1=O
Clc1ccc2nsnc2c1NC1=NCCN1
bioavailability_ma/intrinsic_clearance/intrinsic_or_metabolic_clearance/v2
Fh
a8f393f8724c22e46fac75b166c1616e79fedd325102a2d7b4bd46bc981e6b0b
ext_7
ext_8
4bd7146da9e55bdbbc140f95abaaf4857f24c0d51af630b8522b6cea3ac39104
7720ba5bb8b8a859ca701b52a32586b9fcb72d5456c197f88ef5e1e988ebf9fd
{ "transfer": 0.1001019778934675, "nontransfer": 0.8998980221065325 }
{ "soft_targets": { "(A)": 0.1001019778934675, "(B)": 0.8998980221065325 }, "groups": { "assay_concept": "Fh" }, "target_z": -8.96748346707399 }
138.779835
-8.967483
0.100102
0.899898
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
ef94c8a589d1862cedbe510c84656f41f114f0390d2ebea189dea5bb489a5c68
c52018aef717940d29078dbf23db92ccf1b0a605800d5e5957bb33c0918cadf8
COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1
CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
9b460c4c8448fd3a7fd5ad42a3cf838b75c4e7ddcc075565e5cd90c66f582805
70802
162695
0005db75d10caff08c624141289fabde19a465ffcd09a37daa09003c31f62058
8b303437db707f153b40474aa54f9f47bc42b16eb3a1300410db14575383e86d
{ "transfer": 0.10000000061330895, "nontransfer": 0.8999999993866911 }
{ "soft_targets": { "(A)": 0.10000000061330895, "(B)": 0.8999999993866911 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -20.98900876318283 }
240.066287
-20.989009
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
ef94c8a589d1862cedbe510c84656f41f114f0390d2ebea189dea5bb489a5c68
fe4415b5b99d2e82e51a68641e66f5413bb0cc51b34ad2ea23545ab79ff08df2
COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1
COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
fa4116b0c1392c96fc5601370c9ae2bbb5d58dedecf9d352536d18100fbfc0f2
70802
14279
0005db75d10caff08c624141289fabde19a465ffcd09a37daa09003c31f62058
22d7b515e1a9cf9896fee54d8cecce8c5a5563d4fb0523a4df0becd0e6dc1c27
{ "transfer": 0.10000045769518931, "nontransfer": 0.8999995423048107 }
{ "soft_targets": { "(A)": 0.10000045769518931, "(B)": 0.8999995423048107 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -14.373918276492642 }
180.163235
-14.373918
0.1
0.9
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(B)
train
ef94c8a589d1862cedbe510c84656f41f114f0390d2ebea189dea5bb489a5c68
c4b949ab56a7586968723b0bf1ee2217224d07165fe3a5c35260f13f992a7a1d
COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1
Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
114c9ba6dea338aeda708da74012d1c259c2dc3e2aaa5c4f85e74fc5ea4aa352
70802
19309
0005db75d10caff08c624141289fabde19a465ffcd09a37daa09003c31f62058
f8e4910c17cb1e21fc80b70722a63ce8ad651b52cfaf3d7efa17a0a58a38d07b
{ "transfer": 0.10000468569682258, "nontransfer": 0.8999953143031774 }
{ "soft_targets": { "(A)": 0.10000468569682258, "(B)": 0.8999953143031774 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -12.047846510072977 }
159.099457
-12.047847
0.100005
0.899995
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (...
(A)
train
ef94c8a589d1862cedbe510c84656f41f114f0390d2ebea189dea5bb489a5c68
a88065d8de3175cc97fafbad3b140632e71ccfcf9cc3ebb8e3cf2b5e8290804f
COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1
Cc1cc(O)c(C)c2c1O[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC2
bioavailability_ma/oral_bioavailability/relative_exposure_magnitude/v2
oral_bioavailability
a4c45cf06bd54d26751b4044a8d331f74dd5cdb273f78d21a83d572323229020
70802
162948
0005db75d10caff08c624141289fabde19a465ffcd09a37daa09003c31f62058
f59f64d1db06ceb9fa9cdd802f57a74cccae644a60d56d307aa7cf987f41e3fc
{ "transfer": 0.8937691409724074, "nontransfer": 0.10623085902759255 }
{ "soft_targets": { "(A)": 0.8937691409724074, "(B)": 0.10623085902759255 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 4.847278455584159 }
6.105397
4.847278
0.893769
0.106231
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O...
(B)
train
0b5c7f199141f9bdb19167a0eae75cf35fa515636894179b699c5b3827238e33
b3ca1d725e6f99ff651c9c223388deb82c9755ff7a4e2e57b32ef60a73dce047
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1
bioavailability_ma/auc/auc_exposure/v2
oral_exposure
92413fd8e4a320c9ba0c606813553a81248c9bc634ec60fa13db0cc097806ed5
ext_75
ext_25
01aa565da1e97d0c363bca08cb081048741f5ae47d3715bb2b507f5981f67677
2ac3c9281b039ceb8ab4cb8465b992d56a3b2fe8b6f0f4899545d9bbbac0f09a
{ "transfer": 0.10023615016370456, "nontransfer": 0.8997638498362954 }
{ "soft_targets": { "(A)": 0.10023615016370456, "(B)": 0.8997638498362954 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -8.127603885804296 }
123.59964
-8.127604
0.100236
0.899764
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1</...
(B)
train
0b5c7f199141f9bdb19167a0eae75cf35fa515636894179b699c5b3827238e33
0dea476449c90c01b9632f50a27387802f84e800041dc6197306cab6299eb4df
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
bioavailability_ma/auc/auc_exposure/v2
oral_exposure
b10048b838892663ff9b985a626896e055f17a4f8d6aab0d746ed171305fcd1b
ext_75
ext_12
01aa565da1e97d0c363bca08cb081048741f5ae47d3715bb2b507f5981f67677
76834bd750747056e9cb3e6dcc1f869be0443ae0cd7ffc7b472df4ffdfa3a5f5
{ "transfer": 0.10060907521636563, "nontransfer": 0.8993909247836344 }
{ "soft_targets": { "(A)": 0.10060907521636563, "(B)": 0.8993909247836344 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -7.179663604587135 }
115.015552
-7.179664
0.100609
0.899391
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2</SMILES> ...
(B)
train
0b5c7f199141f9bdb19167a0eae75cf35fa515636894179b699c5b3827238e33
d5641e031d437e349c89fccfc0692df434ff6f06a4a1d6ed488513a066b0d57a
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
bioavailability_ma/auc/auc_exposure/v2
oral_exposure
30ff41bb01711b709f15e769fea387c82608a09a423465de804fc2681529d082
ext_75
ext_5
01aa565da1e97d0c363bca08cb081048741f5ae47d3715bb2b507f5981f67677
1a3c9ab33cd05cb03347bcc1c0f0116513fea3ad262bf371e7c6efd51fc128d8
{ "transfer": 0.2542730634041883, "nontransfer": 0.7457269365958117 }
{ "soft_targets": { "(A)": 0.2542730634041883, "(B)": 0.7457269365958117 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -1.4316525444054773 }
62.964351
-1.431653
0.254273
0.745727
null
false
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=...
(A)
train
0b5c7f199141f9bdb19167a0eae75cf35fa515636894179b699c5b3827238e33
81b51101258210f4f15c978fd93981d7da20c08ec433a0005118b69d5d1f4fbd
O=C(N=c1c(Cl)cn(O)cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O
bioavailability_ma/auc/auc_exposure/v2
oral_exposure
20fbb5c236f44f7aed27d5211e137a8d14d0b0d2082c280ac8ec2e7497dfea61
ext_75
ext_4
01aa565da1e97d0c363bca08cb081048741f5ae47d3715bb2b507f5981f67677
ca13aaaadf1d4b78def7b4f5ead748f6499aabbf25cbd2dbb1bf8bd32dd20fd3
{ "transfer": 0.5811840165095958, "nontransfer": 0.41881598349040416 }
{ "soft_targets": { "(A)": 0.5811840165095958, "(B)": 0.41881598349040416 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": 0.41163568557191194 }
46.272427
0.411636
0.581184
0.418816
null
false
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(B)
train
fba69ae4a3ce8b9b5bd1f6e72152c3757133e3411ad9f9c156ac9ff0fa794303
aa1d621c1f959e868488238710cb867d12102ed12a55b9024f33fcf7fbef1bc5
O=C1C=CC(=Nc2cc(Cl)c(O)c(Cl)c2)C=C1
COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1OC
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
4a2731b35f94d603e8709e2f132b5a2e732bc92a8cd6ba5e8b9cb2121ad779f2
ext_6
ext_31
1ebefe95c7ed03af7a87326d8a9b1a69803fddfbf248d0a00ddc6e5f197a4b52
3a0871726dd54d29379bf67f64254431a58c459fc28a88c19885966466892f9b
{ "transfer": 0.10010131773446516, "nontransfer": 0.8998986822655348 }
{ "soft_targets": { "(A)": 0.10010131773446516, "(B)": 0.8998986822655348 }, "groups": { "assay_concept": "Fh" }, "target_z": -8.97397888677193 }
131.264002
-8.973979
0.100101
0.899899
null
true
null
null
You are comparing two molecules for a hepatic clearance / metabolic stability (Fh) assay. Values reported under different assay systems (e.g. hepatocytes vs. liver microsomes vs. recombinant enzyme) are not directly comparable, so both records below share the same assay system by construction. Two measurements are con...
(B)
train
fba69ae4a3ce8b9b5bd1f6e72152c3757133e3411ad9f9c156ac9ff0fa794303
617b202952b90c969165e911e809195525e5578cbd2d5bc6399768408d8251a6
O=C1C=CC(=Nc2cc(Cl)c(O)c(Cl)c2)C=C1
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O
bioavailability_ma/hepatic_clearance/hepatic_clearance/v2
Fh
902d46c4b864167bc3815df400543a556ff8caf5b29b2fca1c1cd47631adfa95
ext_6
ext_4
1ebefe95c7ed03af7a87326d8a9b1a69803fddfbf248d0a00ddc6e5f197a4b52
7e2a7ba1010de41e93be42fd0567a5e6ce65f7ce65a392345e3b6eccb196767e
{ "transfer": 0.10173971756941033, "nontransfer": 0.8982602824305896 }
{ "soft_targets": { "(A)": 0.10173971756941033, "(B)": 0.8982602824305896 }, "groups": { "assay_concept": "Fh" }, "target_z": -6.128711929106969 }
105.498644
-6.128712
0.10174
0.89826
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
23afb6d306075dab3ba307a11c06fa87a6e1e248264cc1a439865d3b18fba329
9b10d79ce1a4ff681f6d7848e2f737b5f315e2eebc274e15052d16d0a19fdf5c
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21
COc1cc(C)c(Cc2cnc(N)nc2N)cc1OC
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
fe336d6861f46adb55bd8456bef5c4923d703d14053fedcf1a5659cfed507d4f
148472
118195
000527def9bb477a83e456c2119663a2e211ab9b3f360e1b660971603094aeae
af6d63d1141c7785f528b6addc205a2bf540437565a92937a69b011b75afc661
{ "transfer": 0.10013666784950684, "nontransfer": 0.8998633321504932 }
{ "soft_targets": { "(A)": 0.10013666784950684, "(B)": 0.8998633321504932 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -8.674642631323394 }
148.7
-8.674643
0.100137
0.899863
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
23afb6d306075dab3ba307a11c06fa87a6e1e248264cc1a439865d3b18fba329
1e6e05da0d5e1b2d672cf0eb2a160a651cc64225a2cde5b6e38db8561ba1f2da
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21
COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
28fe0a5b0938c49790c017d145096f4478941eaf0175df3f8ef283d56c79275f
148472
86109
000527def9bb477a83e456c2119663a2e211ab9b3f360e1b660971603094aeae
9849762d1e26aa50e874943a58e6db0f2f402d841e850fba4ed69485dab5a862
{ "transfer": 0.10975609756097561, "nontransfer": 0.8902439024390244 }
{ "soft_targets": { "(A)": 0.10975609756097561, "(B)": 0.8902439024390244 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -4.394449154672439 }
100
-4.394449
0.109756
0.890244
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(B)
train
23afb6d306075dab3ba307a11c06fa87a6e1e248264cc1a439865d3b18fba329
89235a7af7092fd2c5c484c3bd4abe6aa28f59a4ea50c01d13cb12e31c56e1ff
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21
Nc1ncnc2c1ncn2CCOCP(=O)(O)O
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
080050cedfe18cdb5bec2a2819911c222d983a759115ee2fd940b66baba65a5e
148472
122907
000527def9bb477a83e456c2119663a2e211ab9b3f360e1b660971603094aeae
c4564256c499ed4615a532702b7e47fd5604a65cb55bac6b3d94de0ef5631682
{ "transfer": 0.18, "nontransfer": 0.8200000000000001 }
{ "soft_targets": { "(A)": 0.18, "(B)": 0.8200000000000001 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": -2.1972245773362196 }
75
-2.197225
0.18
0.82
null
true
null
null
You are comparing two molecules for oral bioavailability. Oral bioavailability is the fraction of an oral dose reaching systemic circulation unchanged. Two measurements are considered to transfer when they are within 10 percentage points of each other, and considered not to transfer once they are 30 percentage points ...
(A)
train
23afb6d306075dab3ba307a11c06fa87a6e1e248264cc1a439865d3b18fba329
52b4681dca03a938bb56d2f5f3e43c690eb741cd4ac88369b41bb25cdd4c5e53
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21
CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O
bioavailability_ma/oral_bioavailability/absolute_bioavailability_percentage/v2
oral_bioavailability
8b24b53be54974775284133f9a3b649bd3bb1affa0775be200ac68d398449915
148472
91842
000527def9bb477a83e456c2119663a2e211ab9b3f360e1b660971603094aeae
5b8c7f569fa93e16be6d5395cc8a86d2a40173dcfe5411b3f896402f90fcb9a7
{ "transfer": 0.881351907670593, "nontransfer": 0.11864809232940698 }
{ "soft_targets": { "(A)": 0.881351907670593, "(B)": 0.11864809232940698 }, "groups": { "assay_concept": "oral_bioavailability" }, "target_z": 3.7352817814715733 }
7.5
3.735282
0.881352
0.118648
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c...
(B)
train
9d781e596cb2c03c6d722ca419e277d9429e107f9ad54fe21a254459b3b393a5
83afd942815842b639b219ffb521e9ec72e299ac89ad28f4ed195b0bd7f15bf9
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1
bioavailability_ma/auc0_t/auc_exposure/v2
oral_exposure
2def5e18bee320b42024589b23baaae21a472568cdd152386fa004a1fabc15ee
ext_29
ext_38
103051d650466b8435fa9d6634efd9340ba66de4fa1c789c8c8f30db11b31a93
1d55ee6de76386e61d330bb85f7babafd38c1a8cd879e8440e0d58b410d53004
{ "transfer": 0.10000002102628078, "nontransfer": 0.8999999789737192 }
{ "soft_targets": { "(A)": 0.10000002102628078, "(B)": 0.8999999789737192 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -17.454349139014123 }
208.058123
-17.454349
0.1
0.9
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12...
(B)
train
9d781e596cb2c03c6d722ca419e277d9429e107f9ad54fe21a254459b3b393a5
e260fd4c6b3c0ecd4a37b8c3079004fba6d759931a18208a96d2155b4600c362
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12
bioavailability_ma/auc0_t/auc_exposure/v2
oral_exposure
d61d7b06c5ffdcce59ea2d4e5ada1f86c9464cc77304078c6eba8ab205ea1492
ext_29
ext_29
103051d650466b8435fa9d6634efd9340ba66de4fa1c789c8c8f30db11b31a93
c3c28a2346d192eea6fe2d1e5963ad1a302bd585a4ba356c960325ac12c8f088
{ "transfer": 0.10034245842237235, "nontransfer": 0.8996575415776277 }
{ "soft_targets": { "(A)": 0.10034245842237235, "(B)": 0.8996575415776277 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": -7.755788586172602 }
120.232661
-7.755789
0.100342
0.899658
null
true
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>O=C(O)[C@H]1O[C@@H](Oc2ccc([C@@H]3[C@@H](CC[C@H...
(A)
train
9d781e596cb2c03c6d722ca419e277d9429e107f9ad54fe21a254459b3b393a5
515a30183de06de882e5bdb32228e05908db84e5c92c22edd38b14c4c677e350
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
O=C(O)[C@H]1O[C@@H](Oc2ccc([C@@H]3[C@@H](CC[C@H](O)c4ccc(F)cc4)C(=O)N3c3ccc(F)cc3)cc2)[C@H](O)[C@@H](O)[C@@H]1O
bioavailability_ma/auc0_t/auc_exposure/v2
oral_exposure
fadf9c67620a4fc07e53ca75c21c2917c3b359efe98231fd540ad306d55ab788
ext_29
ext_11
103051d650466b8435fa9d6634efd9340ba66de4fa1c789c8c8f30db11b31a93
cf45a02d9a1dc8f85040b7335e33f3d231f2e7620a2af100e0024e41c0da6860
{ "transfer": 0.7411172190208299, "nontransfer": 0.25888278097917006 }
{ "soft_targets": { "(A)": 0.7411172190208299, "(B)": 0.25888278097917006 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": 1.3950456054004234 }
37.367143
1.395046
0.741117
0.258883
null
false
null
null
You are comparing two molecules for an oral systemic exposure endpoint. Two measurements are considered to transfer when they are within 2-fold of each other, and considered not to transfer once they are 5-fold or more apart. Molecule A (retrieved measurement) - <SMILES>C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O...
(A)
train
9d781e596cb2c03c6d722ca419e277d9429e107f9ad54fe21a254459b3b393a5
f85ae20915c801b6466acb07b5e0b4c58b91dfb16652add378013274330b61b6
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12
bioavailability_ma/auc0_t/auc_exposure/v2
oral_exposure
f30b3451e280b65595090c72fcb6d7afe536c7bbc358bce2c49549c4771d75ad
ext_29
ext_40
103051d650466b8435fa9d6634efd9340ba66de4fa1c789c8c8f30db11b31a93
51ab5a2f70fc634c2343640e2c974954df900a864208da5d9969e6214c8116bb
{ "transfer": 0.8959324195917143, "nontransfer": 0.10406758040828568 }
{ "soft_targets": { "(A)": 0.8959324195917143, "(B)": 0.10406758040828568 }, "groups": { "assay_concept": "oral_exposure" }, "target_z": 5.276465953835735 }
2.218883
5.276466
0.895932
0.104068
null
true
null
null
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 3-fold of each other, and considered not to transfer once they are 10-fold or more apart. Molecule A (retrieved measurement) - <SMILES>CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)...
(B)
train
cbd073a46483914289f6d4ffd4a7d99b706d03240b05cf9cbe6286de4d82cc41
2fccfc94403c198f1ad86a3f94ac9d8dbd226e6421ff7ce59a2ce9d2cd7c242e
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
bioavailability_ma/intestinal_effective_permeability/peff_unspecified/v2
Fa
fb100291924a27116fe751d7cd81c60592ed69a585cf8af604d98b6e35e31ef8
ext_10
ext_19
010e5e91ea49b2293bb4f5e7d87c29258bf132a20ac30300951bff7a82d37eb3
c3909bddfbd1add456f1c9414a4cf4fe25aa8b630f7e09d56d5a1627efed5dca
{ "transfer": 0.10001466698611237, "nontransfer": 0.8999853330138876 }
{ "soft_targets": { "(A)": 0.10001466698611237, "(B)": 0.8999853330138876 }, "groups": { "assay_concept": "Fa" }, "target_z": -10.906749547347687 }
156.515466
-10.90675
0.100015
0.899985
null
true
null
null
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 3-fold of each other, and considered not to transfer once they are 10-fold or more apart. Molecule A (retrieved measurement) - <SMILES>Cn1c(=O)c2[nH]cnc2n(C)c1=O</SMILES> - measure...
(A)
train
cbd073a46483914289f6d4ffd4a7d99b706d03240b05cf9cbe6286de4d82cc41
e63c79e179ddd525faa2fa53a82c152c5fc0db88e1ed17e8fb3b9a716118c3cd
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
Cn1c(=O)c2[nH]cnc2n(C)c1=O
bioavailability_ma/intestinal_effective_permeability/peff_unspecified/v2
Fa
d0cfc1150a6e79a84b722ef137c3ea6bfd71c8500d0e5cbfc2ab3dff58813532
ext_10
ext_29
010e5e91ea49b2293bb4f5e7d87c29258bf132a20ac30300951bff7a82d37eb3
3fcb56f6d00031c637f5eed7a48708a983118097278b58e63857392e2457d6e8
{ "transfer": 0.7957817265142343, "nontransfer": 0.2042182734857657 }
{ "soft_targets": { "(A)": 0.7957817265142343, "(B)": 0.2042182734857657 }, "groups": { "assay_concept": "Fa" }, "target_z": 1.8985485165289573 }
39.404132
1.898549
0.795782
0.204218
null
false
null
null
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 3-fold of each other, and considered not to transfer once they are 10-fold or more apart. Molecule A (retrieved measurement) - <SMILES>COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC...
(A)
train
cbd073a46483914289f6d4ffd4a7d99b706d03240b05cf9cbe6286de4d82cc41
7eaa7c31568783423c77a2f76df6dc713212006b05521cb0ccb2e3a8c4a3596d
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
bioavailability_ma/intestinal_effective_permeability/peff_unspecified/v2
Fa
84e230d536ac175ff087effcab2ed879c0759a2e866b22f39b3555630f9a6aaa
ext_10
ext_38
010e5e91ea49b2293bb4f5e7d87c29258bf132a20ac30300951bff7a82d37eb3
162a346ed44611ebba663ce3430be14c68ce66538a7acd302b5f28431008e2d3
{ "transfer": 0.8749274809751428, "nontransfer": 0.12507251902485716 }
{ "soft_targets": { "(A)": 0.8749274809751428, "(B)": 0.12507251902485716 }, "groups": { "assay_concept": "Fa" }, "target_z": 3.430997065266106 }
25.389067
3.430997
0.874927
0.125073
null
true
null
null
You are comparing two molecules for an intestinal absorption (Fa) assay. Two measurements are considered to transfer when they are within 3-fold of each other, and considered not to transfer once they are 10-fold or more apart. Molecule A (retrieved measurement) - <SMILES>COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC...
(A)
train
cbd073a46483914289f6d4ffd4a7d99b706d03240b05cf9cbe6286de4d82cc41
ed7f44230a110c8f90412e30315b7f9b58583b00ef1284fc77917d1fb0529f28
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
bioavailability_ma/intestinal_effective_permeability/peff_unspecified/v2
Fa
2b500678912db76b74cef4dd81e6d06d1492c00651b5dae3929b836e19b58627
ext_10
ext_24
010e5e91ea49b2293bb4f5e7d87c29258bf132a20ac30300951bff7a82d37eb3
96b633735ed7c653439ffe0ccce755fe448279fffd554b06c273000db496073f
{ "transfer": 0.8979064810640576, "nontransfer": 0.10209351893594243 }
{ "soft_targets": { "(A)": 0.8979064810640576, "(B)": 0.10209351893594243 }, "groups": { "assay_concept": "Fa" }, "target_z": 5.9431450473848635 }
2.414123
5.943145
0.897906
0.102094
null
true
null
null
End of preview. Expand in Data Studio

Assay Transfer Raw Pair V7.1 Intern

V7.1 is a thin, additive update to V7: same pairing/labeling/rendering design (pipeline/v6_intern.py), same TxAgent-sourced Bioavailability_Ma evidence, but built after TxAgent rebuilt its Fg (gut-wall availability) normalization, and after several diversity/leakage fixes to the train-generation logic itself. Nothing about V7's four original concepts' records changed between the two eligible-records snapshots — this is purely additive plus a train-generation rework.

What changed vs V7

  1. 5th assay concept: Fg. TxAgent's Fg normalization previously produced zero usable records (V7 covered Fa, Fh, oral_bioavailability, oral_exposure only). The rebuilt snapshot yields 1,056 eligible Fg records (462 distinct molecules, gut-wall efflux/secretory-transport assays — Caco-2/MDCK bidirectional permeability, P-gp/BCRP substrate classification). Fg is train-only: it never appears in validation, test, or either ranking split.
  2. Validation/test are frozen to V7's exact held-out molecules, not re-derived from the new (larger, Fg-inclusive) weight distribution. scripts/build_v7_1_intern_raw_pair.py's --split-mode reuse (the default used for this build) recomputes V7's original 1,250+1,250 validation/test molecules deterministically from its untouched eligible-records artifact, so re-deriving a fresh held-out set here can't silently drift the eval population just because Fg added new record weight to the pool. (--split-mode recompute is also available, for deriving a fresh held-out set from this dataset's own distribution instead.)
  3. No cross-split molecule leakage, including for Fg. A new module, pipeline/split_leakage.py, checks any "force this concept into that split" override (here: routing Fg into train) against the base partition and drops exactly the rows that would leak a molecule into two splits, rather than allowing it. 108 of the 1,056 Fg records belong to molecules already held out in V7's validation/test and are dropped outright (not moved, not usable anywhere); the remaining 948 Fg records — including 148 on molecules that don't exist in V7 at all — contribute to train.
  4. Train anchor-frequency skew fixed. V7 had no cap on how often a record could be selected as the query side of a training pair (only the retrieval side was capped at 8) — a heavily-studied molecule with thousands of raw records could dominate query selection by tens of thousands of pairs. TRAIN_QUERY_DEGREE_CAP now bounds this too. Both this and the pre-existing retrieval cap are 6 (each record: at most 6 as query + 6 as retrieval = 12 total appearances), keyed by raw record id, not canonical SMILES (a molecule with many raw records is not deduplicated across them).
  5. Pair-bucket diversity. Query selection now round-robins two levels deep — concept, then pair_bucket_key within that concept, then record within that bucket — instead of a flat per-concept record list, so a mega-bucket with thousands of records no longer gets proportionally thousands of times more query-attempt volume than a small one.
  6. Small buckets can now contribute training pairs. V7 discarded any attempt that didn't produce exactly 4 chosen retrievals, which structurally excluded every pair_bucket_key with fewer than 5 total records (over half of all pairable buckets). Groups can now be 1-4 members wide in the default flat build (--listnet mode is unaffected and keeps the strict requirement, since ListNet's ranking loss assumes a fixed width).
  7. Train volume is a soft target, not a guarantee. Because of the frequency caps above, generation now naturally exhausts (every record in every reachable bucket capped or structurally out of partners) before necessarily reaching the requested pair count. This build requested 1,250,000 flat train pairs and produced 952,346 — build() does not error on falling short, only on producing zero usable pairs.
  8. New templates/assay_transfer_v7_intern/Fg.jinja, matching the existing per-concept template style (see Fa.jinja/Fh.jinja) and using only the context fields TxAgent's Fg schema actually populates (measured process, direction, assay system, intestinal site, transporter/enzyme, substrate status, qualifying conditions, extra details, support text).

Everything else — the sigmoid target, pair_bucket_key condition-key pairing gate, is_decisive column, source-native prompt rendering, query-record leak fixes, and metadata shape — is unchanged from V7 (see its README for details).

The eligible-records adapter and build driver are pipeline/source_normalization/starling_txagent_eligible.py and scripts/build_v7_1_intern_raw_pair.py (a thin wrapper importing V7's build script directly, not a copy).

Target

d = abs(comparison_value_retrieval - comparison_value_query)
z = log(9) * (transfer_max + not_transfer_min - 2*d) / (not_transfer_min - transfer_max)
q_A = eps + (1 - 2*eps) * sigmoid(z / T)      # eps = 0.1, T = 1 (label smoothing)
q_B = 1 - q_A

comparison_value/transfer_max/not_transfer_min are all in TxAgent's own normalized (0–100) distance space rather than raw physical units.

Splits

  • train — 952,346 flat directed pairs (one row per pair; requested 1,250,000, see point 7 above). All 5 concepts, including Fg.
  • validation / test — 1,000 decisive comparisons each (125 per concept × 2 labels × 4 concepts — Fg excluded).
  • validation_ranking / test_ranking — 500 distinct-molecule anchors × 20 candidates = 10,000 comparisons each (Fg excluded).

All five splits share one schema (split-specific columns null-filled). Zero molecule overlap between train and validation/test, verified directly against the built parquet files. Intern tokenization is pinned to jiosephlee/Intern-S1-mini-lm revision fcb667c380ae01f57693a45b4b5c2d331052a107.

Known limitations

Inherited from V7 (see its README): confidence/molecule_name not included; canonical_assay_system is fuzzy-matched for ~3.3% of valid TxAgent records.

Specific to V7.1: under --split-mode recompute, a molecule whose only eligible records are Fg can be selected into the fresh validation/test held-out set purely on Fg record weight, then lose all its rows once Fg is excluded from eval — so that mode's held-out molecule count can land slightly under the 1,250/1,250 target (observed ~1,238/1,241). This build used --split-mode reuse (the default), which does not have this issue.

Downloads last month
21